Soquelitinib Atopic Dermatitis Phase 1 Clinical Trial Data From Cohorts 1-3 anticipated to be Presented in MayInitial Results From First Two ...

After every meal, the intestines perform an action called peristalsis - moving food through their hollow interiors with coordinated contractions and relaxations of the smooth muscle.

Glenmark Pharmaceuticals Ltd. (Glenmark), a leading research-led, global pharmaceuticals company has partnered with, Health Futures Foundation ...

Contemplated merger with Decoy Therapeutics progressing as planned; upon closing, combined company expected to accelerate clinical development of ...

New magnetic nanoparticles in the shape of a cube sandwiched between two pyramids represent a breakthrough for treating ovarian tumors and possibly other types of cancer, according to the Oregon State ...

“Switching horses midstream” is an idiom that means to abruptly change leaders or strategies in the middle of a crucial task, often suggesting that such a change is not a good idea and could lead to ...

LEWES, Del., March 18, 2025 /PRNewswire/ -- The global corrugated board packaging market is projected to grow from approximately USD 250 billion in 2024 to nearly USD 420 billion by 2032, reflecting a ...

PlayStation has announced its new first-party game development studio, Dark Outlaw Games, fronted by Call of Duty lead Jason ...

This investment will help build a 103,000-square-foot R&D center and a GMP manufacturing facility in Edmonton, Alberta. The biomanufacturing facility will develop and produce the Entos Fusogenix ...

From its origins in a garage to becoming one of the most recognisable symbols in the world, explore the story behind the iconic Apple logo design. Apple is a company that has changed the technology ...

Collegium Pharmaceutical Inc. is a specialty pharma ... (crushing and injecting, etc.). The design combines an active opioid ingredient with a fatty acid and waxes to form microspheres that ...

MAHWAH, N.J., March 3, 2025 /PRNewswire/ -- Glenmark Pharmaceuticals Inc., USA (Glenmark) announces the Acquisition and launch 1 of Acetylcysteine Injection, 6 gm/30 mL (200 mg/mL) Single-Dose Vials.